AtriCure, Inc.
ATRC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $134 | $136 | $124 | $124 |
| % Growth | -1.4% | 10.1% | -0.5% | – |
| Cost of Goods Sold | $33 | $35 | $31 | $32 |
| Gross Profit | $101 | $101 | $93 | $93 |
| % Margin | 75.5% | 74.5% | 74.9% | 74.5% |
| R&D Expenses | $23 | $29 | $23 | $35 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $78 | $78 | $76 | $72 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $101 | $108 | $99 | $107 |
| Operating Income | $0 | -$6 | -$6 | -$15 |
| % Margin | 0.2% | -4.5% | -4.8% | -11.7% |
| Other Income/Exp. Net | -$0 | $0 | -$1 | -$1 |
| Pre-Tax Income | -$0 | -$6 | -$7 | -$15 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$6 | -$7 | -$16 |
| % Margin | -0.2% | -4.5% | -5.5% | -12.5% |
| EPS | -0.01 | -0.13 | -0.14 | -0.33 |
| % Growth | 92.3% | 7.1% | 57.6% | – |
| EPS Diluted | -0.01 | -0.13 | -0.14 | -0.33 |
| Weighted Avg Shares Out | 48 | 48 | 47 | 47 |
| Weighted Avg Shares Out Dil | 48 | 48 | 47 | 47 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $1 | $1 |
| Interest Expense | $3 | $1 | $1 | $1 |
| Depreciation & Amortization | $5 | $5 | -$1 | $5 |
| EBITDA | $8 | $1 | -$6 | -$9 |
| % Margin | 5.9% | 0.5% | -4.8% | -7.3% |